Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Express Scripts
Citi
Deloitte
Colorcon
AstraZeneca
Harvard Business School
Chinese Patent Office
QuintilesIMS

Generated: December 12, 2018

DrugPatentWatch Database Preview

Drug Price Trends for CAPTOPRIL

« Back to Dashboard

Drug Price Trends for CAPTOPRIL

Average Pharmacy Cost for CAPTOPRIL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CAPTOPRIL 12.5 MG TABLET 00378-3007-10 0.70067 EA 2018-11-21
CAPTOPRIL 12.5 MG TABLET 00781-8052-01 0.70067 EA 2018-11-21
CAPTOPRIL 50 MG TABLET 00904-5047-61 1.14675 EA 2018-11-21
CAPTOPRIL 12.5 MG TABLET 00378-3007-01 0.70067 EA 2018-11-21
CAPTOPRIL 12.5 MG TABLET 00904-5045-61 0.70067 EA 2018-11-21
CAPTOPRIL 12.5 MG TABLET 00781-8052-10 0.70067 EA 2018-11-21
CAPTOPRIL 12.5 MG TABLET 00143-1171-01 0.70067 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for CAPTOPRIL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CAPTOPRIL 12.5MG TAB 10X10 Mylan Institutional, Inc. 51079-0863-20 100UD 114.98 1.14980 EA 2017-11-15 - 2022-09-29 FSS
CAPTOPRIL 25MG TAB Mylan Institutional, Inc. 51079-0864-20 100UD 124.83 1.24830 EA 2017-11-15 - 2022-09-29 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
Teva
Argus Health
Harvard Business School
Queensland Health
US Department of Justice
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.